Skip to main content
Top
Published in: Drugs & Aging 12/2008

01-12-2008 | Original Research Article

Older Patients’ Perceptions of Medication Importance and Worth

An Exploratory Pilot Study

Authors: Dr Denys T. Lau, Becky A. Briesacher, Nathaniel D. Mercaldo, Leslie Halpern, E. Charles Osterberg, Mary Jarzebowski, June M. McKoy, Kathleen Mazor

Published in: Drugs & Aging | Issue 12/2008

Login to get access

Abstract

Background: Cost-related medication non-adherence may be influenced by patients’ perceived importance of their medications.
Objectives: This exploratory pilot study addresses three related but distinct questions: Do patients perceive different levels of importance among their medications? What factors influence perceptions of medication importance? Is perceived importance associated with perceived worth of medications, and does expense impact on that association?
Methods: Study participants included individuals aged ≥60 years who were taking three or more prescription drugs. Semi-structured, in-person interviews were conducted to measure how patients rated their medications in terms of importance, expense and worth. Factors that influenced medication importance were identified using qualitative analysis. Ordinal logistic regression analyses were employed to examine the association between perceived importance and perceived worth of medications, and the impact of expense on that association.
Results: For 143 prescription drugs reported by 20 participants, the weighted mean rating of medication importance was 8.2 (SD 1.04) on a scale from 0 (not important at all) to 10 (most important). Patients considered 38% of these medications to be expensive. The weighted mean rating of worth was 8.4 (SD 1.46) on a scale from 0 (not worth it at all) to 10 (most worth). Three major factors influenced medication importance: drug-related (characteristics, indications, effects and alternatives); patient-related (knowledge, attitudes and health); and external (the media, healthcare and family caregivers, and peers). Regression analyses showed an association between perceived importance and perceived worth for inexpensive medications (odds ratio [OR] 2.23; p = 0.002) and an even greater association between perceived importance and perceived worth for expensive medications (OR 4.29; p < 0.001).
Discussion: This study provides preliminary evidence that elderly patients perceive different levels of importance for their medications based on factors beyond clinical efficacy. Their perception of importance influences how they perceive their medications’ worth, especially for medications of high costs. Understanding how patients perceive medication importance may help in the development of interventions to reduce cost-related non-adherence.
Literature
1.
go back to reference Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med 2007; 22(6): 864–71PubMedCrossRef Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med 2007; 22(6): 864–71PubMedCrossRef
2.
go back to reference Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002; 287(3): 337–44PubMedCrossRef Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 2002; 287(3): 337–44PubMedCrossRef
3.
go back to reference Heisler M, Langa KM, Eby EL, et al. The health effects of restricting prescription medication use because of cost. Med Care 2004; 42(7): 626–34PubMedCrossRef Heisler M, Langa KM, Eby EL, et al. The health effects of restricting prescription medication use because of cost. Med Care 2004; 42(7): 626–34PubMedCrossRef
4.
go back to reference Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Affairs 2005; Suppl Web Exclusives: W5-152–W5-166 Safran DG, Neuman P, Schoen C, et al. Prescription drug coverage and seniors: findings from a 2003 national survey. Health Affairs 2005; Suppl Web Exclusives: W5-152–W5-166
5.
go back to reference Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med 2001; 16(12): 793–9PubMedCrossRef Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med 2001; 16(12): 793–9PubMedCrossRef
6.
go back to reference Leibowitz A, Manning WG, Newhouse JP. The demand for prescription drugs as a function of cost-sharing. Soc Sci Med 1985; 21(10): 1063–9PubMedCrossRef Leibowitz A, Manning WG, Newhouse JP. The demand for prescription drugs as a function of cost-sharing. Soc Sci Med 1985; 21(10): 1063–9PubMedCrossRef
7.
go back to reference Lohr KN, Brook RH, Kamberg CJ, et al. Use of medical care in the Rand Health Insurance Experiment: diagnosis- and service-specific analyses in a randomized controlled trial. Med Care 1986; 24 (9 Suppl.): S1–87PubMed Lohr KN, Brook RH, Kamberg CJ, et al. Use of medical care in the Rand Health Insurance Experiment: diagnosis- and service-specific analyses in a randomized controlled trial. Med Care 1986; 24 (9 Suppl.): S1–87PubMed
8.
go back to reference Goldman DP, Joyce GF, Escarce JJ, et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA 2004; 291(19): 2344–50PubMedCrossRef Goldman DP, Joyce GF, Escarce JJ, et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA 2004; 291(19): 2344–50PubMedCrossRef
9.
go back to reference Tseng CW, Brook RH, Keeler E, et al. Cost-lowering strategies used by Medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA 2004; 292(8): 952–60PubMedCrossRef Tseng CW, Brook RH, Keeler E, et al. Cost-lowering strategies used by Medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA 2004; 292(8): 952–60PubMedCrossRef
10.
go back to reference Harris BL, Stergachis A, Ried LD. The effect of drug copayments on utilization and cost of Pharmaceuticals in a health maintenance organization. Med Care 1990; 28(10): 907–17PubMedCrossRef Harris BL, Stergachis A, Ried LD. The effect of drug copayments on utilization and cost of Pharmaceuticals in a health maintenance organization. Med Care 1990; 28(10): 907–17PubMedCrossRef
11.
go back to reference Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am J Public Health 2004; 94(10): 1782–7PubMedCrossRef Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am J Public Health 2004; 94(10): 1782–7PubMedCrossRef
12.
go back to reference Soumerai SB, Ross-Degnan D, Avorn J, et al. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med 1991; 325(15): 1072–7PubMedCrossRef Soumerai SB, Ross-Degnan D, Avorn J, et al. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med 1991; 325(15): 1072–7PubMedCrossRef
13.
go back to reference Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001; 285(4): 421–9PubMedCrossRef Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001; 285(4): 421–9PubMedCrossRef
14.
go back to reference Boardman AE, Greenberg DH, Vining AR, et al. Cost-benefit analysis: concepts and practice. Upper Saddle River (NJ): Prentice Hall, 1996 Boardman AE, Greenberg DH, Vining AR, et al. Cost-benefit analysis: concepts and practice. Upper Saddle River (NJ): Prentice Hall, 1996
15.
go back to reference Mitchell RC, Carson RT. Using surveys to value public goods: the contingent value method. Baltimore (MD): Johns Hopkins Press, 1989 Mitchell RC, Carson RT. Using surveys to value public goods: the contingent value method. Baltimore (MD): Johns Hopkins Press, 1989
16.
go back to reference Davis TC, Long SW, Jackson RH, et al. Rapid estimate of adult literacy in medicine: a shortened screening instrument. Fam Med 1993; 25(6): 391–5PubMed Davis TC, Long SW, Jackson RH, et al. Rapid estimate of adult literacy in medicine: a shortened screening instrument. Fam Med 1993; 25(6): 391–5PubMed
17.
go back to reference Davis TC, Michielutte R, Askov EN, et al. Practical assessment of adult literacy in health care. Health Educ Behav 1998; 25(5): 613–24PubMedCrossRef Davis TC, Michielutte R, Askov EN, et al. Practical assessment of adult literacy in health care. Health Educ Behav 1998; 25(5): 613–24PubMedCrossRef
18.
go back to reference Glaser B, Strauss AL. The discovery of grounded theory: strategies for qualitative research. Chicago (IL): Aldine, 1967 Glaser B, Strauss AL. The discovery of grounded theory: strategies for qualitative research. Chicago (IL): Aldine, 1967
19.
go back to reference Gilbert N. Researching social life. London: Sage Publications, 1995 Gilbert N. Researching social life. London: Sage Publications, 1995
20.
go back to reference Miles MB, Huberman AM. Qualitative data analysis: an expanded sourcebook. London: Sage Publications, 1994 Miles MB, Huberman AM. Qualitative data analysis: an expanded sourcebook. London: Sage Publications, 1994
21.
go back to reference Long J, Freese J. Regression models for categorical outcomes using stata. 2nd ed. College Station (TX): Stata Press, 2005 Long J, Freese J. Regression models for categorical outcomes using stata. 2nd ed. College Station (TX): Stata Press, 2005
22.
go back to reference Tjia J, Givens J, Karlawish J, et al. Beneath the surface: discovering the unvoiced concerns of older adults with type 2 diabetes mellitus. Health Educ Res 2008; 23(1): 40–52PubMedCrossRef Tjia J, Givens J, Karlawish J, et al. Beneath the surface: discovering the unvoiced concerns of older adults with type 2 diabetes mellitus. Health Educ Res 2008; 23(1): 40–52PubMedCrossRef
23.
go back to reference Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods 2006; 18: 59–82CrossRef Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods 2006; 18: 59–82CrossRef
24.
go back to reference Weiler SC, Romney AK. Systematic data collection. Qualitative research methods. Vol. 10. Newbury Park (CA): Sage Publications, 1988 Weiler SC, Romney AK. Systematic data collection. Qualitative research methods. Vol. 10. Newbury Park (CA): Sage Publications, 1988
Metadata
Title
Older Patients’ Perceptions of Medication Importance and Worth
An Exploratory Pilot Study
Authors
Dr Denys T. Lau
Becky A. Briesacher
Nathaniel D. Mercaldo
Leslie Halpern
E. Charles Osterberg
Mary Jarzebowski
June M. McKoy
Kathleen Mazor
Publication date
01-12-2008
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 12/2008
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/0002512-200825120-00007

Other articles of this Issue 12/2008

Drugs & Aging 12/2008 Go to the issue

Acknowledgments

Acknowledgement

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.